Vectura Group

Philip Morris to acquire inhaled drug provider Vectura Group for $1.2bn
Pharmaceutical Business Review
Mon, 07/12/21 - 10:52 am
Philip Morris
Vectura Group
inhaled drugs
drug manufacturing